Report of Foreign Issuer (6-k)
August 15 2017 - 4:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report
of Foreign Private Issuer Pursuant to Rule
13a-16 or 15d-16
Under
the Securities Exchange Act
of 1934
For the Month of August 2017
001-37521
(Commission File Number)
INTEC PHARMA LTD.
(Translation of registrant’s name into
English)
12 Hartom Street
Har Hotzvim, Jerusalem 9777512, Israel
(+972) (2) 586-4657
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover
Form 20-F or Form 40-F.
Form 20-F
☒
Form 40-F
☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(l): _________
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): _________
EXPLANATORY
NOTE
On August 15, 2017,
Intec Pharma Ltd. issued a press release announcing the launch of an underwritten public offering of its ordinary shares. A copy
of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
Intec Pharma Ltd.
|
|
|
Date: August 15, 2017
|
By:
|
/s/ Nir Sassi
|
|
|
Nir Sassi
|
|
|
Chief Financial Officer
|
Exhibit
Index
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Apr 2024 to May 2024
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Intec Parent Inc (NASDAQ): 0 recent articles
More Intec Pharma Ltd. News Articles